Navigation Links
Integrated BioPharma's Proprietary Vaccine Technology Achieves,Strong Positive Results

HILLSIDE, NJ, March 12, 2007—InB:Biotechnologies, Inc. ("BioTech"), a wholly-owned subsidiary of Integrated BioPharma, Inc. (NASDAQ: INBP), today announced strong positive results in studies of vaccines against HPV, anthrax and plague made using INBP's novel, proprietary AIPwLV™ vaccine technology. The studies were conducted by the Fraunhofer USA Center for Molecular Biotechnology (CMB), the Contract Research Organization led by Dr. Vidadi Yusibov, through which BioTech executes its vaccine-related development activities.

The results, reported in the respected peer-reviewed scientific journal Vaccine, demonstrated pre-clinical efficacy of key HPV proteins produced by the AIPwLV™ technology, which induced specific immune responses and protected against HPV challenge infection. HPV is the primary etiologic agent of cervical cancer, which represents the third leading cause of cancer-related death among women worldwide. The reported results support the possibility of producing prophylactic and therapeutic HPV vaccines using the AIPwLV™ technology.

The studies also demonstrated that other vaccine candidates made using the AIPwLV™ technology induced specific immune responses and conferred complete protection against lethal doses of anthrax and plague, two substances considered as likely bioterrorism agents.

"The AIPwLV™ technology achieves rapid, high level production of antigens, antibodies and therapeutic proteins in non-genetically modified plants utilizing a proprietary launch-vector technology," said Dr. Yusibov, the Executive Director of CMB. "It offers rapid, unparalleled scalability of vaccine production and cost efficiency, addressing the principal concerns affecting current methods of vaccine production, particularly where large scale or rapid inoculation is desired," added Dr. Yusibov.

About Integrated BioPharma, Inc. Integrated BioPharma is a
'"/>




Page: 1 2

Related medicine technology :

1. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
2. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
3. Neurogen Announces Positive Results for Proprietary Insomnia Drug in Two Chronic Insomnia Clinical Trials
4. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
7. Neurogen Proprietary Insomnia Compound Data Presented at Associated Professional Sleep Societies Annual Meeting
8. Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting
9. Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
10. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
11. Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention

Post Your Comments:
(Date:11/9/2009)...9 Milestone Scientific I...der in computer-controlled injection technologies,...tented, award-winning STA Single Tooth Anesthesia...5th year of TBSE titled "The Love Dentistry Fest 2.... ,, The STA System is a computer-controlle...
(Date:11/9/2009)... Access MediQuip, LLC, the nation,...able medical device management solutions to the he...cating its corporate headquarters to Lake Mary, Fl... rapid growth, includes a major expansion of the P... in January 2010 and relocation and expansion of t...
(Date:11/9/2009)...re-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasda...m the Company,s Bepreve(TM) (bepotastine besilate .... These results were presented in poster sessions...e of Allergy, Asthma & Immunology (ACAAI) in M...tled, "Treatment of Ocular Itching with Bepotastin...
Breaking Medicine Technology:Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Dysport Added as a Procedure on AmericanHealthandBeauty com 3A Let the Wrinkle Wars Begin 49447 1Dysport Added as a Procedure on AmericanHealthandBeauty com 3A Let the Wrinkle Wars Begin 49447 2Dysport Added as a Procedure on AmericanHealthandBeauty com 3A Let the Wrinkle Wars Begin 49447 3Special Olympics Minnesotas 2009 Summer Games Continue 49443 1Special Olympics Minnesotas 2009 Summer Games Continue 49443 2Special Olympics Minnesotas 2009 Summer Games Continue 49443 3China Animal Welfare Law Under Review While 36 000 Dogs Culled 4615 1China Animal Welfare Law Under Review While 36 000 Dogs Culled 4615 2
...S, the Netherlands, June 11, 2007-Sugammadex - the...ng developed by Organon,the human healthcare busi...III pivotal trial a 9-12 times faster reversal of,... without evidence,of post operative residual curar...on.1, 2 The results of this pivotal Aurora trial,w...
...ASHINGTON, DC, June 11, 2007 /PRNewswire-FirstCall...d Medicine at Georgetown,University Medical Center...of Neurochem Inc.,s North American Phase III clini...sent today an update on,Neurochem,s investigationa...,s disease (AD). The presentation by Dr. Aisen wil...
Other Medicine Technology:Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4
(Date:11/9/2009)...mood despite similar weight loss , , MON...ow-carbohydrate diet such as the popular Atkins pr... people lose pounds over the course of a year. ,...sult in long-term improvement in mood, according t...rnal Medicine . , People on both diets consumed...
(Date:11/9/2009)...-FirstCall/ - Hard To Treat Diseases (HTDS.PK) ww... a US$41 billion international healthcare company,...artner, Zhejiang Tianyuan Bio-Pharmaceutical Co., ...will begin a five-year, $1 billion China initiativ...rease its investment in its China R&D facility...
(Date:11/9/2009)...ffered in April 2010, Provides First Responders wi...ambridge, MA (Vocus) November 9, 2009 -- When Stef...rst inspected a suspected mass grave at Dasht-e-L...team of experts to help interpret the scene. He kn...rst step in securing evidence of a human rights vi...
(Date:11/9/2009)...swire/ -- Actress Mariska Hargitay and the Joyfu...rday to raise awareness about the need for domesti...by building healing and wellness kits for women in...e one to each of the estimated 600 women currently...tic violence shelters. ,, "Our goal is to shine...
(Date:11/9/2009)...hlighting a commitment to providing long-term heal...d digital display technology options, LG Electroni...pital Grade LCD HDTVs this week at the Association...eeting and exposition (booth #1760). ,, On disp..." Long-Term Care LCD HDTVs bring a sense of home a...
Breaking Medicine News(10 mins):Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5
...ancer, anyone? Yes, Oxford University researchers ...vent bowel cancer developing . Taking a dose of 30... Long-term aspirin use is generally not backed ... published in the Lancet - which examined data fro...
...lockbuster drug could be in for some trouble times... A panel of experts advising the US Food and Dru...drug could indeed be overused. In some cases it co...ther much more data on erythropoietin's safety. ...
...ent of heart attack, the 90-minute goal for inflat...y artery to restore normal blood flow is so rever...ditation standards, and pay-for-performance progra...diovascular Angiography and Interventions (SCAI). ...
...ntists have develop a vaccine which they claim wil...ol their blood pressure . The vaccine deve...een successfully tested and is expected in the mar...ver. Angiotensin raises blood pressure by narrowin...
...dent is in hospital here with a fractured shoulder... failing to bring a book. Sugam Kumar Sin...lish literature book on Friday and this infuriated...her asked him to go out of school. Sugam w...
...the well-known activist, who had been crusading fo...s has dropped her lawsuit against the federal gov...l system, I don't understand how somebody can lose...py about having to give up the case. "But I'...
Other Medicine News:Health News:Aspirin can Prevent Bowel Cancer, Says UK Study 2Health News:Anemia Drug Overused and Could Hasten Death in Some, Say Experts 2Health News:Anemia Drug Overused and Could Hasten Death in Some, Say Experts 3Health News:Debate Focuses on Door-to-balloon Time in Heart Attack Treatment 2Health News:Medical Marijuana Activist Drops Lawsuit 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: